Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry G. who wrote (712)	6/18/2000 6:55:00 PM
From: Sean Janzen	Read Replies (2) of 792

Larry, The following link is to Harbor-UCLA Research and Education Institute: rei.edu I know nothing of this institution but suspect that any products to reach human clinical trials from this collaboration will come years from now. At that time, MBI will be an established company. What I find far more interesting it this link to the FDA. fda.gov click on "antibiotics" then scroll up to the heading Section 112 - Fast Track Drug Development and click on "Guidance". Read the article: Guidance for Industry - Fast Track Drug Development Programs - Designation, Development, and Application Review. I suspect that MBI's 2 other products in Human Clinical Trials, MBI 594AN and MBI 853NL, will qualify for fast track approval. MBI could have 3 products in or qualified for Phase III within 6-12 months, just my opinion. Sean p.s. I still believe the Recap web site is accurate in suggesting MBI 226 is undergoing Human Clinical Trials for the secondary indication severe acne. MBI has not responded to my email on this question.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next